169 related articles for article (PubMed ID: 22114048)
1. Lymphocytic colitis secondary to ipilimumab treatment.
García-Varona A; Odze RD; Makrauer F
Inflamm Bowel Dis; 2013 Feb; 19(2):E15-6. PubMed ID: 22114048
[No Abstract] [Full Text] [Related]
2. Types of colitis based on histology.
Sherid M; Ehrenpreis ED
Dis Mon; 2011 Sep; 57(9):457-89. PubMed ID: 21944389
[No Abstract] [Full Text] [Related]
3. A severe case of ipilimumab-induced guillain-barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis.
Gaudy-Marqueste C; Monestier S; Franques J; Cantais E; Richard MA; Grob JJ
J Immunother; 2013 Jan; 36(1):77-8. PubMed ID: 23211620
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for IPILIMUMAB-Related Colitis-Letter.
Arriola E; Wheater M; Karydis I; Thomas G; Ottensmeier C
Clin Cancer Res; 2015 Dec; 21(24):5642-3. PubMed ID: 26672088
[No Abstract] [Full Text] [Related]
5. Ipilimumab-induced colitis: a rare but serious side effect.
Hinds AM; Ahmad DS; Muenster JE; Berg ZM; Lopez KT; Holly JS; Matteson-Kome ML; Bechtold ML
Endoscopy; 2014; 46 Suppl 1 UCTN():E308-9. PubMed ID: 25058826
[No Abstract] [Full Text] [Related]
6. Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity.
Grover S; Srivastava A
Cancer; 2019 Jun; 125(11):1768-1770. PubMed ID: 30892689
[No Abstract] [Full Text] [Related]
7. Clostridium difficile infection may loom behind ipilimumab-induced auto-immune colitis.
Du-Thanh A; Pallure V; Girard C; Dereure O; Guillot B
Eur J Dermatol; 2015; 25(4):344. PubMed ID: 25905620
[No Abstract] [Full Text] [Related]
8. Colitis associated with biological agents.
Khirfan K; Kistin M
Dig Dis Sci; 2014 Jun; 59(6):1112-4. PubMed ID: 24756315
[No Abstract] [Full Text] [Related]
9. Ipilimumab-induced colitis in patients with metastatic melanoma.
De Felice KM; Gupta A; Rakshit S; Khanna S; Kottschade LA; Finnes HD; Papadakis KA; Loftus EV; Raffals LE; Markovic SN
Melanoma Res; 2015 Aug; 25(4):321-7. PubMed ID: 25933207
[TBL] [Abstract][Full Text] [Related]
10. Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis.
Beniwal-Patel P; Matkowskyj K; Caldera F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):274. PubMed ID: 26405697
[No Abstract] [Full Text] [Related]
11. Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital.
Rastogi P; Sultan M; Charabaty AJ; Atkins MB; Mattar MC
World J Gastroenterol; 2015 Apr; 21(14):4373-8. PubMed ID: 25892889
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
Ali AK; Watson DE
Pharmacotherapy; 2017 Nov; 37(11):1383-1390. PubMed ID: 28950039
[TBL] [Abstract][Full Text] [Related]
13. Microscopic colitis and endoscopy.
Koulaouzidis A
Neth J Med; 2009 Oct; 67(9):316. PubMed ID: 19841492
[No Abstract] [Full Text] [Related]
14. Lymphocytic colitis associated with entacapone.
Rodrigues DM; Hsieh E; Bernstein M; Juurlink DN
CMAJ; 2022 Oct; 194(40):E1377-E1380. PubMed ID: 36252980
[No Abstract] [Full Text] [Related]
15. The cost of ipilimumab toxicity: a single-centre analysis.
Yousaf N; Davidson M; Goode E; Thomas C; Hung R; Gore M; Larkin J
Melanoma Res; 2015 Jun; 25(3):259-64. PubMed ID: 25860328
[TBL] [Abstract][Full Text] [Related]
16. Association between ipilimumab and celiac disease.
Gentile NM; D'Souza A; Fujii LL; Wu TT; Murray JA
Mayo Clin Proc; 2013 Apr; 88(4):414-7. PubMed ID: 23541015
[TBL] [Abstract][Full Text] [Related]
17. Ipilimumab granulomatous interstitial nephritis.
Thajudeen B; Madhrira M; Bracamonte E; Cranmer LD
Am J Ther; 2015; 22(3):e84-7. PubMed ID: 24067875
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity.
Gutzmer R; Koop A; Meier F; Hassel JC; Terheyden P; Zimmer L; Heinzerling L; Ugurel S; Pföhler C; Gesierich A; Livingstone E; Satzger I; Kähler KC;
Eur J Cancer; 2017 Apr; 75():24-32. PubMed ID: 28214654
[TBL] [Abstract][Full Text] [Related]
19. [Lymphocytic colitis secondary to phlebotomic drug intake].
Gonzalez J; Arribas J; Ramos J; Hernandez F; Page A; Herrero F
Gastroenterol Hepatol; 2000; 23(6):313. PubMed ID: 15324631
[No Abstract] [Full Text] [Related]
20. Ipilimumab-induced Ocular and Orbital Inflammation--A Case Series and Review of the Literature.
Papavasileiou E; Prasad S; Freitag SK; Sobrin L; Lobo AM
Ocul Immunol Inflamm; 2016; 24(2):140-6. PubMed ID: 25760920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
